NHC Comments on OIG Clinical Trial Participation RFI August 24, 2026 The Honorable T. March Bell Inspector General Office of Inspector General Department of Health and Human Services Cohen Building […]
Drug Pricing Program
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029 August 17, 2026 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of […]
NHC Responds to Senate RFI on Drug Costs
NHC Responds to Senate RFI on Drug Costs August 17, 2026 The Honorable Ron Wyden Ranking Member Committee on Finance United States Senate Washington, DC 20510 Dear Ranking Member Wyden: […]
340B Policy Analysis and Discussion Webinar
340B Policy Analysis and Discussion Webinar Event Time: 11:00 a.m. ET – 12:00 p.m. ET Event Location: Virtual As policymakers and stakeholders consider changes to the 340B Drug Pricing Program, […]